139nok
-0,9 %
Date:2025-10-07Time:18:00:00Latest report:Q4-2020List:Oslo GrowthTicker:ONCIN
Market Cap:136 mnokEnterprise Value:136 mnokNet Sales:- mnokEarnings:- mnokEmployees:0ISIN:NO0010779341

Ratios

10-year key figure history for Oncoinvent turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Oncoinvent with index and moving average MA50 and MA200.

Stockprice:1,39
MA50:1,44
MA200:1,92
Price/MA200:-27,8 %
RSI (14):49,1
Price/MA50:-3,9 %

Description

Oncoinvent is a clinical phase radiopharmaceutical company developing treatments for solid cancers. The technology platform is focused on the use of alpha-emitting radionuclides to deliver radiation directly to cancer cells. The Company's product candidate, Radspherin®, is an alpha radiation therapy candidate designed for the local treatment of cancer that has spread to body cavities. Oncoinvent has its headquarters in Oslo.

Medical Equipment